Ledger.Open graph →
SEC Form D · filed February 16, 2016

BeneVir Biopharm, Inc

Offering
$12.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Gaithersburg, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Matthew C. Mulvey · Rocvkille, MDExec · DirectorDavid C. Present · New York, NYDirectorDavid C. Kirn · Emeryville, CADirectorKatherine A. Sacksteder · Rockville, MDExec · DirectorCherine C. Plumaker · New York, NYDirectorMatthew C. Mulvey · Rocvkille, MDExec · DirectorDavid C. Present · New York, NYDirectorDavid C. Kirn · Emeryville, CADirectorKatherine A. Sacksteder · Rockville, MDExec · DirectorCherine C. Plumaker · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗